The Forbes Institute offers bold, cross-departmental funding opportunities with a goal of fueling game-changing initiatives that drive breakthroughs in cancer research
For information on submissions, please contact:
Kristin Van Raaphorst, MPA
Programs Administrator
Research Administrative Services
U-M Rogel Cancer Center
Researchers at the Rogel Cancer Center have developed a new diagnostic approach using artificial intelligence that aims to do exactly that — and with greater than 90% accuracy
Researchers at the Medicine C.S Mott Children’s Hospital and the U-M Rogel Cancer Center have been breaking new ground in understanding and treating childhood brain cancers, including some of the most serious and aggressive types of tumors.
Using a technique called single-cell RNA sequencing, a research team from U-M was able to show for the first time how individual cells within a single population of cancer cells respond differently to the DNA damage caused by chemotherapy.
Researchers at the University of Michigan have discovered a new potential treatment approach for DIPG. One that significantly lengthened survival times in two mouse models.
With a new $7.2 million grant from the National Cancer Institute, Rogel Cancer Center researchers and their national collaborators will test whether blocking inflammatory processes could protect cells and potentially prevent some cancers.
By distilling information from hundreds of data sources, including published genome-wide association studies (GWAS) and meta-analyses, Rogel Cancer Center researchers generated polygenic risk scores (PRS) for 35 common types of cancer.
MENU
